National Bank of Canada’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
VCM
VPM
DAM
National Bank of Canada's RMD Position: Q1 2026 in Review
National Bank of Canada reduced its ResMed (RMD) stake by 35% in Q1 2026, selling an estimated $8.41M and leaving 62,905 shares worth $14.1M. The position accounts for 0.01% of the portfolio, ranked #594.
National Bank of Canada first reported a position in RMD in Q4 2021 and has held it in 18 quarters since. The position peaked at $34.7M in Q2 2025. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- National Bank of Canada held 62,905 shares of ResMed worth $14.1M as of Q1 2026.
- National Bank of Canada sold 33,758 ResMed shares in Q1 2026, an estimated $8.41M.
- ResMed made up 0.01% of National Bank of Canada's portfolio in Q1 2026, its #594 holding.
- National Bank of Canada first reported a position in ResMed in Q4 2021 and has held it in 18 quarters since.
- National Bank of Canada's ResMed position peaked at $34.7M in Q2 2025.
- 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.